TWiV 1090: Clinical update with Dr. Daniel Griffin
In his weekly clinical update, Dr. Griffin reviews recent statistics on the circulation of respiratory syncytial virus before discussing uptake of the RSV vaccine Abrysvo or the monoclonal anti-RSV antibody nirsevimab to prevent severe disease following RSV infection in infants 8 months or younger before going over this week’s influenza virus and SARS-CoV-2 virus statistics, including all circulating variants in the US, examines if self-testing is more accurate than clinician administered Binax rapid diagnostic tests for SARS-CoV-2 infection, if N95 masks need a yearly fitting, how SARS-CoV-2 vaccination impacts the prev...
Source: This Week in Virology - MP3 Edition - February 24, 2024 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
Why we need to rethink how we talk about cancer
For over a century, cancer has been classified by areas of the body - lung cancer, breast cancer, skin cancer etc. And yet modern medical research is telling us that the molecular and genetic mechanisms behind cancers are not necessarily tied to parts of the body. Many drugs developed to treat metastatic cancers have the capacity to work across many different cancers, and that presents an opportunity for more tailored and efficient treatments. Oncologists are calling for a change in the way patients, clinicians and regulators think about naming cancers.In this podcast, senior comment editor Lucy Odling-...
Source: Nature Podcast - February 9, 2024 Category: Science Authors: Springer Nature Limited Source Type: podcasts
Toripalimab for Lung Cancer, Breast Cancer Mortality, Epochs of Health AI and Monitoring Its Use in Practice, and more
Editor’s Summary by Mary McGrae McDermott, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the January 16, 2024, issue. Related Content: Audio Highlights (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - January 16, 2024 Category: General Medicine Authors: JAMA Network Source Type: podcasts
JAMA Oncology : Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer
Interview with Kenneth L. Kehl, MD, MPH, author of Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer in the US ALCHEMIST Study (Alliance A151216). Hosted by Jack West, MD. (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - March 17, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
JAMA Otolaryngology –Head & Neck Surgery : Incidence of Second Primary Lung Cancer After Lung Cancer Screening in Head and Neck Cancer Survivors
Interview with John D. Cramer, MD, author of Incidence of Second Primary Lung Cancer After Low-Dose Computed Tomography vs Chest Radiography Screening in Survivors of Head and Neck Cancer: A Secondary Analysis of a Randomized Clinical Trial (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - October 28, 2021 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
JAMA Oncology : Hypofractionated Image-Guided vs Conventional Radiotherapy for Patients With NSCLC
Interview with Puneeth Iyengar, MD, PhD, author of Accelerated Hypofractionated Image-Guided vs Conventional Radiotherapy for Patients With Stage II/III Non–Small Cell Lung Cancer and Poor Performance Status: A Randomized Clinical Trial (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - August 12, 2021 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
JAMA Oncology : Neuronal Autoantibodies and Cognitive Impairment in Patients With Lung Cancer
Interview with Carsten Finke, MD, and Frederik Bartels, MD, authors of Association Between Neuronal Autoantibodies and Cognitive Impairment in Patients With Lung Cancer (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - July 1, 2021 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
JAMA Oncology : Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint –Based Therapy in Patients With Advanced NSCLC
Interview with Charu Aggarwal, MD, and Lova Sun, MD, authors of Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint Inhibitor–Based Therapy in Patients With Advanced Non–Small-Cell Lung Cancer (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - April 15, 2021 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
USPSTF Recommendation —Screening for Lung Cancer
Interview with Michael J. Barry, MD, author of USPSTF Recommendation—Screening for Lung Cancer (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - March 11, 2021 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Lung Cancer Screening Guideline Update, Polypharmacy in Dementia, Spinal Surgery for Cervical Spondylotic Myelopathy, and more
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the March 9, 2021 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - March 9, 2021 Category: General Medicine Authors: JAMA Network Source Type: podcasts
JAMA Oncology : Survival and Adjuvant Chemotherapy in Early-Stage NSCLC With vs Without Clinicopathologic Features
Interview with Daniel J Boffa, MD, author of Association of Survival With Adjuvant Chemotherapy Among Patients With Early-Stage Non–Small Cell Lung Cancer With vs Without High-Risk Clinicopathologic Features (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - September 17, 2020 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
JAMA Oncology : Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases
Interview with Chad G. Rusthoven, MD, author of Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases: The FIRE-SCLC Cohort Study (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - June 4, 2020 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
JAMA Oncology : Durvalumab With or Without Tremelimumab vs Standard Chemotherapy for Metastatic NSCLC
Interview with Naiyer A. Rizvi, MD, author of Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non–Small Cell Lung Cancer: The MYSTIC Phase 3 Randomized Clinical Trial (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - April 9, 2020 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
Talk Evidence - testing under the microscope and opioid prescription
This edition of talk evidence was recorded before the big increase in covid-19 infections in the UK, and then delayed by some self isolation. We'll be back with more evidence on the pandemic very soon.
As always Duncan Jarvies is joined by Helen Macdonald (resting GP and editor at The BMJ) and Carl Heneghan (active GP, director of Oxford University’s CEBM and editor of BMJ Evidence).
in this episode
(1.01) Helen talks about variation in prescription of opioids - do 1% of clinician really pres cribe the vast majority of the drug?
(8.45) Carl tells us that its time papers (in this case a lung screening one) really pres...
Source: The BMJ Podcast - March 20, 2020 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Talk Evidence - testing under the microscope and opioid prescription
This edition of talk evidence was recorded before the big increase in covid-19 infections in the UK, and then delayed by some self isolation. We'll be back with more evidence on the pandemic very soon.
As always Duncan Jarvies is joined by Helen Macdonald (resting GP and editor at The BMJ) and Carl Heneghan (active GP, director of Oxford University’s CEBM and editor of BMJ Evidence).
in this episode
(1.01) Helen talks about variation in prescription of opioids - do 1% of clinician really prescribe the vast majority of the drug?
(8.45) Carl tells us that its time papers (in this case a lung screening one) really presen...
Source: The BMJ Podcast - March 20, 2020 Category: General Medicine Authors: BMJ Group Source Type: podcasts
